Weekly Update: May 16, 2022
Black Swan Connection Newsletter Signup
Breaking News
Never a bad time to follow one of the sharpest investors ever. Of course, every economic trend either good or bad has winners and if you are astute enough to find the silver lining amongst the wreckage you can win big time
Here are the latest picks from the legend himself, Warren Buffett.
Just do what he says, no need to ask questions….
Marketwise 5-16-22
Warren Buffett says these are the best stocks to own when inflation spikes — with consumer prices still surging, it’s time to follow his lead.
American Express ( AXP)
Coca Cola (KO)
Apple (AAPL)
Chevron (CVX)
From the Guru
Price levels continue to rise at a rate we haven’t seen in decades. In April, U.S. consumer prices surged 8.3% — down slightly from 8.5% in March, but still near 40-year highs.
Spiking inflation has severe consequences for your cash savings.
Fortunately, investing legend Warren Buffett has plenty of advice on what to own when consumer prices spike.
In a 1981 letter to shareholders, Buffett highlighted two business traits that investors should look for when trying to fight inflation: 1) the power to increase prices easily, and 2) the ability to take on more business without having to spend excessively.
Corporate News
Sponsored by:
The 21st Century Investment Bank Capital Raises + Strategic Advisory
Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.
Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.
For more information go to: www.DonaldCapital-NY.com
The Premier Operating System for Publicly Traded Companies
Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.
Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.
Click Here For a Sequire Power Point Presentation
To schedule a demo email me at cdilley@smm.global or call 727-459-7378
5-10-2022 SRAX (NASDAQ: SRAX)
NSAV Announces Partnership with SRAX to Enhance Investor Communications
London, England, May 10, 2022 (GLOBE NEWSWIRE) — Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced that they have entered into a partnership with SRAX (NASDAQ: SRAX) to maximize and accelerate its communications for interested investors, shareholders, and supporters.
Through SRAX, a publicly traded company offering premier operating system tools for publicly traded companies, NSAV will have the ability to further reach its community through sophisticated solutions to assist it in maintaining, communicating, and expanding its shareholder base.
5-2-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF)
Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary
– $6.5 million all-cash transaction, including milestone payments
– Enables exclusive focus on drug pipeline
TORONTO, May 02, 2022–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce the signing of a binding agreement to sell its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”), a leading Canadian full-service distributor of pharmaceuticals and medical devices to dental professionals.
4-19-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
Transaction expected to accelerate Coeptis’ ability to progress its innovative cell therapy platforms for cancer
David Mehalick of Coeptis to serve as Chief Executive Officer;
Chris Calise of Bull Horn to join the Board of Directors
Merger anticipated to close in third quarter 2022; combined company anticipated to list on Nasdaq
WEXFORD, Pa., and MIAMI, Fla., April 19, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, and Bull Horn Holdings Corp. (Nasdaq: BHSE) (“Bull Horn”), a special purpose acquisition company (SPAC), today announced they have entered into a definitive merger agreement for a business combination that will result in Coeptis becoming a wholly-owned subsidiary of Bull Horn. Under the terms of the merger agreement, a wholly-owned subsidiary of Bull Horn will merge with and into Coeptis and the holders of the outstanding Coeptis shares will receive equity in Bull Horn valued at $175 million (subject to adjustments).
04-13-2022 Coeptis Therapeutics, Inc. OTC COEP
Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company has agreed to enter into a strategic agreement with Coeptis Therapeutics, Inc. (OTC PINK: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, to sell Statera’s rights to Entolimod and other related toll-like receptor 5 (TLR5) agonists. The consummation of the transaction is contingent upon negotiation of a definitive agreement and satisfaction of a number of closing conditions, including a contingency on Coeptis financing.
3-30-2022 SRAX (NASDAQ: SRAX)
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA
LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.
LD Micro is host to the most influential conferences in the small and microcap world. Chris Lahiji, founder of the prestigious function, notes the success of the Main Event last October as a “great success that restored humanity within our industry. People could finally see each other and connect again in person. As a result, the upcoming Invitational was the fastest sell-out in our history.”
New on the Scene is Ecrid, Inc. taking on the establishment with a new and improved credit reporting system.
Check it out!!
10-15 2021 Ecrid, Inc (OTC ECDD)
ECRID, the New Credit Bureau Files New IPO
STUART, Fla. , Oct. 15, 2021 /PRNewswire/ — ECRID (OTC: ECDD) is the New Credit Bureau ( www.ECRID.com ) that offers each member the opportunity to create their own personal ECRID Credit Report with conventional and unconventional creditors that they have paid on time to validate their credit worthiness (rental payments included) to lenders. Each Credit Report Holder starts out with a Perfect 950 Credit Score.
An ECRID executive said, “We’re extremely excited and thrilled to prepare to launch one of the most exciting and novel Fintech Credit Lending platforms of its kind, at a time where a large percentage of adults have cash flow, but unfortunately deemed to have poor credit scores.”
First, ECRID Bill Pay Service is second to none. ECRID Credit Report Holders will pay their monthly bills listed on their ECRID Credit Report, through an automated ECRID Electronic Payment System. Once payment is processed, the ECRID Credit Score and payment status will update in real time on the ECRID User’s Credit Report. This process and method gives Lenders validation on how each ECRID Credit Report Holder pays their bills. Secondly, ECRID Credit Report Holders will be able to apply for loans (Home, Auto & Personal loans) inside their ECRID Business Center. Lenders will have access to sign up at www.ECRID.com to become a member and offer their services to the ECRID Credit Report Holders who are looking for financing. The goal is to start offering lending services in November 2021 . ECRID Lenders will be asked not to pull an Equifax, Experion, or Transunion credit report, but instead, base their Novel Fintech Sector Lending on the actual individual user’s ECRID Credit Report. This will give the ECRID User (borrower) a fresh start and a second chance at reestablishing themselves as credit-worthy borrowers. The company’s (ECRID) primary objective is to base the lending decision on the user’s (borrower) ECRID Credit Report along with the user’s (borrower) income-to-debt ratio.
03-07-2021 CanB Corp (OTC CANB)
Greenridge Global Research update
Up To 100 CBD Lab Lounges To Be Launched
Up To 100 CBD Lab Lounges To Be Launched. Yesterday, the Company announced a ten-year deal with American Development Partners (“ADP”) to finance and develop up to 100 CBD Lounges, similar to CANB’s Lab2 format at its Miami facility. The Lab2 concept, which is nearing completion, features a bar/lounge consumption area with viewing windows to see products, like gummies and gelato, being made. The ADP-developed lounges are expected to be similar, having a bar/lounge space with viewing windows to see various end products being produced. The lounges will serve CANB as a relatively cheap way to establish regional production and distribution, enable it to build its brands on a national level, engage in a wider range of product R&D, and increase branded product sales in the lounges. ADP has budgeted $4 million for each lounge (committing $200 million with an option for another $200 million), and will receive a 10% development fee and a 20-year lease on each lounge from CANB. No additional details were released, other than the Company noting no equity was involved in the deal. ADP has a history of real estate development projects, with clients ranging from Wendy’s, Subway, Hampton Inn, Gold’s Gym, and AutoZone, among many other nationwide chains.
01-20-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics Establishes Scientific Advisory Board to Advance Cell Therapy Product Development
Newly formed Scientific Advisory Board includes three members from the prestigious Karolinska Institutet (KI)
WEXFORD, Pa., Jan. 20, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announces the formation of its Scientific Advisory Board (SAB), which will contribute key guidance on the advancement of the Company’s product portfolio highlighted by CD38-GEAR-NK, a cell therapy technology, and CD38-Diagnostic, an in vitro diagnostic, which the company is co-developing with VyGen-Bio, Inc.
The Scientific Advisory Board is comprised initially of three renowned scientific researchers from the Karolinska Institutet, Stockholm, Sweden; Evren Alici, M.D., Ph.D.; Hans-Gustaf Ljunggren, M.D., Ph.D; and Arnika Kathleen Wagner, Ph.D.
Alternative Investments
Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama
3700 Acre Private Island in the Las Perlas Islands
7.4 Acre beachfront paradise for development or private retreat
Message me on Linkedin and check our latest commercial listings:
https://www.linkedin.com/in/carldilley/
Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
Black Swan Connection Newsletter Signup
May 16, 2022 COMPANY QUOTES, LISTINGS RESEARCH AND NEWS Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD) Profile Antibe Therapeutics, Inc (ATBPF) Profile 11/11/2018 News Can B Corp (CANB) Profile News Endurance Exploration Group, Ltd (EXPL) Profile 03-26/19 News Social Reality, Inc. (SRAX) Profile News |
May 6, 2022
ValuEngine Weekly Report
Why Pay More for Your Investments?
May 6, 2022 by Herb Blank
Consumers have never been happy about paying more for the same (or less) from one place than from another. It has only been within the past twenty years or so that investors have gotten wiser to this practice. Financial advisors, planners and the media have increasingly made investors more aware of how much less expensive and tax-efficient ETFs are than mutual funds using the traditional redeem-at-distributor structure. When one adds in tax-efficiency, faster clearing and settlement, intraday liquidity and zero redemption fees, there is almost no reason to pay up for new purchases of traditionally structured mutual funds.
Read Complete Report
ValuEngine new strategies, Podcast introduction
ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.
VIEW JORDAN’S INTRODUCTORY PODCAST HERE
on www.ValuEngine.com
To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE
Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE
Black Swan Research Coverage and Subscription Service
Click Here>>
Event Calendar Updates
SRAX To Host the LD Micro Invitational at the Four Seasons Hotel in Westlake Village, CA
LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, will host the 2022 LD Micro Invitational, a prominent 3-day investor conference, at the Four Seasons Hotel Westlake Village on June 7th-9th, 2022.
For more information on LD Micro, visit ldmicro.com.
Rocky Mountain Microcap Conference IX.
Event will be held May 25, 2022 conference at TopGolf in Centennial Colorado
As with past conferences, Rocky Mountain Microcap Conference IX will be a single-track, single day, 13 company event. Each presenter will be allotted 25-minutes and we expect the conference to run from approximately 10 am until 5:30 pm followed by drinks, dinner and golf. Lunch will be served as well. Unlike, like our past few events, this conference we will be an in-person event only as we will not be providing a virtual option.
dave@trickleresearch.com
Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter
-SMM Distribution Update-
Distribution (Reach)
SMM Global Twitter Acct (Impressions last 30 days) 520
SMM Global Facebook Page (Reach last-30 days) 6,462
SMM Linkedin Pages (contacts) 1,100
SMM Youtube Channel (followers) 6
SMM Instagram Page * (followers) 11
Direct Email * 220,000
Total 256,460